Abstract Purpose The second International Consensus Conference on B3 lesions was held
in Zurich, Switzerland, in March 2018, organized by the International Breast Ultrasound …

Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …

The heterogeneous group of B3 lesions in the breast harbors lesions with different
malignant potential and progression risk. As several studies about B3 lesions have been …

The evaluation and management of dermatologic diseases of the breast and nipple requires
an understanding of the unique anatomy of the breast and nipple and an awareness of the …

Lobular neoplasia (LN) is an atypical proliferation of small, dyscohesive epithelial cells
within the terminal duct lobular unit (TDLU), with or without pagetoid extension and …

More than 10% of breast biopsies performed based on findings at mammography yield
highrisk lesions (HRLs). 1 HRLs refer to a group of heterogeneous lesions that can be …

Purpose The introduction of breast screening in the UK led to an increase in the detection of
non-invasive breast neoplasia, predominantly ductal carcinoma in situ (DCIS), a non …

Lobular neoplasia (LN) is a term that describes the continuum of atypical epithelial lesions
originating in the terminal duct-lobular unit (TDLU) of the breast. 1 To predict cancer risk …

Purpose We analysed incidence, treatment, survival, occurrence of ductal carcinoma in situ
(DCIS) and invasive breast cancer (IBC) after lobular carcinoma in situ (LCIS) in the …

Purpose: Classical type of lobular neoplasia (LN) encompassing both atypical lobular
hyperplasia and classical lobular carcinoma in situ of the breast is a lesion with uncertain …